Literature DB >> 18407220

Autoregulation and crossregulation of nuclear receptor genes.

J R Tata1.   

Abstract

Whereas crossregulation of nuclear receptors has been known for some time, recently several examples of autoregulation have been described, especially during development and specific gene expression. In this review, I discuss both these phenomena, based on some studies from our laboratory on amphibian metamorphosis and egg protein gene expression. These include autoinduction of estrogen receptor (ER) accompanying egg protein gene expression in adult and larval Xenopus; autoinduction of thyroid hormone receptor (TR) during metamorphosis and in adult Xenopus; crossregulation by triiodothyronine (T(3)) and dexamethasone of autoinduction of ER; and inhibition by PRL of autoinduction and crossinduction of TR and ER genes. A dual receptor threshold model to explain the interplay between T(3), estrogen and PRL is presented and its significance to the general question of nuclear receptor autoregulation and crossregulation during development is also discussed.

Entities:  

Year:  1994        PMID: 18407220     DOI: 10.1016/1043-2760(94)p3203-j

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  2 in total

1.  A Mechanism to Enhance Cellular Responsivity to Hormone Action: Krüppel-Like Factor 9 Promotes Thyroid Hormone Receptor-β Autoinduction During Postembryonic Brain Development.

Authors:  Fang Hu; Joseph R Knoedler; Robert J Denver
Journal:  Endocrinology       Date:  2016-02-17       Impact factor: 4.736

2.  Trichoplax adhaerens reveals a network of nuclear receptors sensitive to 9-cis-retinoic acid at the base of metazoan evolution.

Authors:  Jan Philipp Novotný; Ahmed Ali Chughtai; Markéta Kostrouchová; Veronika Kostrouchová; David Kostrouch; Filip Kaššák; Radek Kaňa; Bernd Schierwater; Marta Kostrouchová; Zdenek Kostrouch
Journal:  PeerJ       Date:  2017-09-29       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.